UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 274

Sortiert nach

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

Gastroenterology (New York, N.Y. 1943), 2004-11, Vol.127 (5), p.1347-1355

2004

Volltextzugriff (PDF)

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial

PloS one, 2016, Vol.11 (1), p.e0144917-e0144917

2016

Volltextzugriff (PDF)

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy

British journal of clinical pharmacology, 2017-03, Vol.83 (3), p.498-509

2017

Volltextzugriff (PDF)

Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment

Journal of antimicrobial chemotherapy, 2014-01, Vol.69 (1), p.200-210

2014

Volltextzugriff (PDF)

A potential role for daptomycin in enterococcal infections: what is the evidence?--authors' response

Journal of antimicrobial chemotherapy, 2011-05, Vol.66 (5), p.1196-1197

2011

Volltextzugriff (PDF)

Public health case for microbiome-sparing antibiotics and new opportunities for drug development

mSphere, 2024-08, p.e0041724

2024

Volltextzugriff (PDF)

A potential role for daptomycin in enterococcal infections: what is the evidence?

Journal of antimicrobial chemotherapy, 2010-06, Vol.65 (6), p.1126-1136

2010

Volltextzugriff (PDF)

High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: meta-analysis and implications

Arthritis research & therapy, 2016-03, Vol.18 (73), p.73-73, Article 73

2016

Volltextzugriff (PDF)

Clinical experience with daptomycin in Europe: the first 2.5 years

Journal of antimicrobial chemotherapy, 2011-04, Vol.66 (4), p.912-919

2011

Volltextzugriff (PDF)

Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection

Journal of antimicrobial chemotherapy, 2009-07, Vol.64 (1), p.151-158

2009

Volltextzugriff (PDF)

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database

Journal of antimicrobial chemotherapy, 2013-07, Vol.68 (7), p.1642-1649

2013

Volltextzugriff (PDF)

Daptomycin for the treatment of infective endocarditis: results from a European registry

Journal of antimicrobial chemotherapy, 2013-04, Vol.68 (4), p.936-942

2013

Volltextzugriff (PDF)

Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial

Drugs & aging, 2013-10, Vol.30 (10), p.829-836

2013

Volltextzugriff (PDF)

Effectiveness and safety of daptomycin in complicated skin and soft-tissue infections and bacteraemia in clinical practice: Results of a large non-interventional study

International journal of antimicrobial agents, 2013-04, Vol.41 (4), p.372-378

2013

Volltextzugriff (PDF)

Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience

International journal of antimicrobial agents, 2013-05, Vol.41 (5), p.468-472

2013

Volltextzugriff (PDF)

Efficacy and safety of diclofenac in osteoarthritis: Results of a network meta-analysis of unpublished legacy studies

Scandinavian journal of pain, 2017-07, Vol.16 (1), p.74-88

2017

Volltextzugriff (PDF)

Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections

Journal of the American Podiatric Medical Association, 2014-03, Vol.104 (2), p.159

2014

Volltextzugriff (PDF)

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORESM database

Journal of antimicrobial chemotherapy, 2013-07, Vol.68 (7), p.1642-1649

2013

Volltextzugriff (PDF)

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE super(SM) database

Journal of antimicrobial chemotherapy, 2013-07, Vol.68 (7), p.1642-1649

2013

Volltextzugriff (PDF)

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE^sup SM^ database

Journal of antimicrobial chemotherapy, 2013-07, Vol.68 (7), p.1642

2013

Volltextzugriff (PDF)

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naive HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial: e0144917

PloS one, 2016-01, Vol.11 (1)

2016

Volltextzugriff (PDF)

Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients

Journal of medical virology, 1996-09, Vol.50 (1), p.71-74

1996

Volltextzugriff (PDF)

Molecular epidemiology of an outbreak of hepatitis A in Italy

Journal of medical virology, 1995-12, Vol.47 (4), p.467-471

1995

Volltextzugriff (PDF)

Specific detection of minus strand hepatitis A virus RNA by Tail-PCR following reverse transcription

Nucleic acids research, 1994-05, Vol.22 (10), p.1919-1920

1994

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(258)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy

Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment

A potential role for daptomycin in enterococcal infections: what is the evidence?--authors' response

Public health case for microbiome-sparing antibiotics and new opportunities for drug development

A potential role for daptomycin in enterococcal infections: what is the evidence?

High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: meta-analysis and implications

Clinical experience with daptomycin in Europe: the first 2.5 years

Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database

Daptomycin for the treatment of infective endocarditis: results from a European registry

Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial

Effectiveness and safety of daptomycin in complicated skin and soft-tissue infections and bacteraemia in clinical practice: Results of a large non-interventional study

Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience

Efficacy and safety of diclofenac in osteoarthritis: Results of a network meta-analysis of unpublished legacy studies

Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections

FDA, CDC, and NIH Co-sponsored Public Workshop Summary—Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORESM database

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE super(SM) database

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE^sup SM^ database

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naive HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial: e0144917

Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients

Molecular epidemiology of an outbreak of hepatitis A in Italy

Specific detection of minus strand hepatitis A virus RNA by Tail-PCR following reverse transcription

Suchergebnisse filtern